VOMITING is the #8 most commonly reported adverse reaction for METFORMIN, manufactured by Granules Pharmaceuticals Inc.. There are 14,691 FDA adverse event reports linking METFORMIN to VOMITING. This represents approximately 2.3% of all 631,481 adverse event reports for this drug.
Patients taking METFORMIN who experience vomiting should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
Reporting Frequency
VOMITING14,691 of 631,481 reports
VOMITING is a less commonly reported adverse event for METFORMIN, but still significant enough to appear in the safety profile.
Other Side Effects of METFORMIN
In addition to vomiting, the following adverse reactions have been reported for METFORMIN:
VOMITING has been reported as an adverse event in 14,691 FDA reports for METFORMIN. This does not prove causation, but indicates an association observed in post-market surveillance data.
How common is VOMITING with METFORMIN?
VOMITING accounts for approximately 2.3% of all adverse event reports for METFORMIN, making it a notable side effect.
What should I do if I experience VOMITING while taking METFORMIN?
If you experience vomiting while taking METFORMIN, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.